Document Detail


Betulinic acid suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase SHP-1 in human multiple myeloma cells.
MedLine Citation:
PMID:  19937797     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
STAT3 activation has been associated with survival, proliferation and invasion of various human cancers. Whether betulinic acid, a pentacyclic triterpene, can modulate the STAT3 pathway, was investigated in human multiple myeloma (MM) cells. We found that betulinic acid inhibited constitutive activation of STAT3, Src kinase, JAK1 and JAK2. Pervanadate reversed the betulinic acid-induced downregulation of STAT3 activation, suggesting the involvement of a protein tyrosine phosphatase (PTP). Furthermore, betulinic acid induced the expression of the PTP SHP-1 and silencing of the SHP-1 gene abolished the ability of betulinic acid to inhibit STAT3 activation and rescued betulinic acid-induced cell death. Betulinic acid also downregulated the expression of STAT3-regulated gene products such as bcl-xL, bcl-2, cyclin D1 and survivin. This correlated with an increase in apoptosis as indicated by an increase in the sub-G1 cell population and an increase in caspase-3-induced PARP cleavage. Consistent with these results, overexpression of constitutive active STAT3 significantly reduced the betulinic acid-induced apoptosis. Betulinic acid also enhanced the apoptosis induced by thalidomide (from 10 to 55%) and bortezomib (from 5 to 70%) in MM cells. Overall, our results suggest that betulinic acid downregulates STAT3 activation through upregulation of SHP-1, and this may have potential in sensitization of STAT3 overexpressing tumors to chemotherapeutic agents.
Authors:
Manoj K Pandey; Bokyung Sung; Bharat B Aggarwal
Related Documents :
12520167 - Okadaic acid decreases the leptin content in isolated mouse fat pads.
2059337 - Molecular cloning of the mouse lysosomal acid phosphatase.
3013807 - Phosphatase cytochemistry with cerium as trapping agent. verification of acid phosphata...
2338077 - Type 5 acid phosphatase. sequence, expression and chromosomal localization of a differe...
24012777 - N-3 polyunsaturated fatty acids and her2-positive breast cancer: interest of the fat-1 ...
19071427 - Determination of total antioxidant capacity by a new spectrophotometric method based on...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of cancer. Journal international du cancer     Volume:  127     ISSN:  1097-0215     ISO Abbreviation:  Int. J. Cancer     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-05-26     Completed Date:  2010-06-22     Revised Date:  2014-04-08    
Medline Journal Info:
Nlm Unique ID:  0042124     Medline TA:  Int J Cancer     Country:  United States    
Other Details:
Languages:  eng     Pagination:  282-92     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents, Phytogenic / pharmacology*
Apoptosis / drug effects
Blotting, Western
Boronic Acids / pharmacology
Cell Proliferation / drug effects
Drug Therapy, Combination
Electrophoretic Mobility Shift Assay
Enzyme Activation / drug effects
Flow Cytometry
Humans
Immunoenzyme Techniques
Immunosuppressive Agents / pharmacology
Interleukin-6 / pharmacology
Janus Kinase 1 / metabolism
Janus Kinase 2 / metabolism
Luciferases / metabolism
Multiple Myeloma / drug therapy*,  metabolism,  pathology
Protease Inhibitors / pharmacology
Protein Tyrosine Phosphatase, Non-Receptor Type 6 / genetics,  metabolism*
Pyrazines / pharmacology
STAT3 Transcription Factor / genetics,  metabolism*
Signal Transduction / drug effects*
Thalidomide / pharmacology
Triterpenes / pharmacology*
Tumor Cells, Cultured
src-Family Kinases / metabolism
Grant Support
ID/Acronym/Agency:
P01 CA124787/CA/NCI NIH HHS; P01 CA124787-020002/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Antineoplastic Agents, Phytogenic; 0/Boronic Acids; 0/Immunosuppressive Agents; 0/Interleukin-6; 0/Protease Inhibitors; 0/Pyrazines; 0/STAT3 Transcription Factor; 0/STAT3 protein, human; 0/Triterpenes; 0/bortezomib; 4G6A18707N/betulinic acid; 4Z8R6ORS6L/Thalidomide; EC 1.13.12.-/Luciferases; EC 2.7.010.2/JAK1 protein, human; EC 2.7.10.2/JAK2 protein, human; EC 2.7.10.2/Janus Kinase 1; EC 2.7.10.2/Janus Kinase 2; EC 2.7.10.2/src-Family Kinases; EC 3.1.3.48/PTPN6 protein, human; EC 3.1.3.48/Protein Tyrosine Phosphatase, Non-Receptor Type 6
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Recombinant single-chain variable fragment antibodies against extracellular epitopes of human multid...
Next Document:  Conserved cellular function and stress-mediated regulation among members of the proteolipid protein ...